ArticleFrontiers in bioengineering and biotechnology2025
Non-invasive bio-electromagnetic monitoring of cerebrovascular function: a novel conductivity reactivity index (CRx) for optimal cerebral perfusion pressure in acute brain injury models.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The pressure reactivity index (PRx) is a key predictor of cerebrovascular function, widely used to guide and optimize therapeutic strategies in patients with acute brain injury. This study investigates a non-invasive bio-electromagnetic technique for monitoring and maintaining cerebrovascular function in a rabbit model of acute brain injury. Methods: A coaxial parallel double-coil sensor was designed to detect changes in intracranial electromagnetic properties, measured as magnetic induction phase shifts (MIPS), which reflect cerebral blood volume fluctuations. A cerebrovascular function monitoring platform was constructed with this sensor, a vector network analyzer, a LabVIEW software platform, and a physiological signal acquisition device to record the MIPS and arterial blood pressure (ABP). In the animal experiment, a novel cerebrovascular function index Conductivity Reactivity index (CRx), established with MIPS and ABP, was to assess optimal cerebral blood perfusion pressure (CPP) for maintaining the cerebrovascular function in four gradients of CPP in acute brain injury model. Results: The results found that the CRx (-0.072 ± 0.203) was a significant negative correlation with the PRx (0.223 ± 0.203) (r = -0.447, P = 0.003). Under the optimal CPP determined by the CPP-CRx curve, the mean CRx (0.104 ± 0.170) indicated normal cerebrovascular function, which was significantly different from the other states (CRx = -0.127 ± 0.061, p = 0.009). Discussion: The study demonstrated that CRx has potential to reflect cerebrovascular function dynamics and assess optimal CPP, demonstrating the potential of bio-electromagnetic technology as a noninvasive indicator for monitoring cerebrovascular function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.